#$%^&*AU2018101559A420181213.pdf#####ABSTRACT The present invention provides the use of a molecular marker for early screening for sudden death and a kit for early screening for sudden death. The molecular marker is selected from the RYR2 gene, the RYR3 gene or the KCNQ5 gene. 1